162 related articles for article (PubMed ID: 38035641)
1. Fasting and postprandial plasma glucose contributions to hemoglobin A1c and time in range in people with diabetes on multiple daily injection insulin therapy: Results from the PRONTO-T1D and PRONTO-T2D clinical trials.
Piras de Oliveira C; Dellva MA; Bue-Valleskey J; Chang AM; Liao B
J Diabetes Complications; 2024 Jan; 38(1):108648. PubMed ID: 38035641
[TBL] [Abstract][Full Text] [Related]
2. Fasting and postprandial plasma glucose contribution to glycated haemoglobin and time in range in people with type 2 diabetes on basal and bolus insulin therapy: Results from a pooled analysis of insulin lispro clinical trials.
Liao B; Chen Y; Chigutsa F; Piras de Oliveira C
Diabetes Obes Metab; 2021 Jul; 23(7):1571-1579. PubMed ID: 33687790
[TBL] [Abstract][Full Text] [Related]
3. Rapid-Acting Insulin Analogues Versus Regular Human Insulin: A Meta-Analysis of Effects on Glycemic Control in Patients with Diabetes.
Nicolucci A; Ceriello A; Di Bartolo P; Corcos A; Orsini Federici M
Diabetes Ther; 2020 Mar; 11(3):573-584. PubMed ID: 31873857
[TBL] [Abstract][Full Text] [Related]
4. Ultra-Rapid Lispro Improves Postprandial Glucose Control and Time in Range in Type 1 Diabetes Compared to Lispro: PRONTO-T1D Continuous Glucose Monitoring Substudy.
Malecki MT; Cao D; Liu R; Hardy T; Bode B; Bergenstal RM; Bue-Valleskey J
Diabetes Technol Ther; 2020 Nov; 22(11):853-860. PubMed ID: 32453647
[No Abstract] [Full Text] [Related]
5. Ultra rapid lispro improves postprandial glucose control versus lispro in combination with basal insulin: a study based on CGM in type 2 diabetes in China.
Yuan L; Luo Y; Luo Y; Ding B; Zhang P; Ma J; Wu J
Front Endocrinol (Lausanne); 2024; 15():1364585. PubMed ID: 38774225
[TBL] [Abstract][Full Text] [Related]
6. The Effect of Reduced Self-Monitored Blood Glucose Testing After Adoption of Continuous Glucose Monitoring on Hemoglobin A1c and Time in Range.
Puhr S; Calhoun P; Welsh JB; Walker TC
Diabetes Technol Ther; 2018 Aug; 20(8):557-560. PubMed ID: 30036082
[TBL] [Abstract][Full Text] [Related]
7. Beyond HbA1c.
Bloomgarden Z
J Diabetes; 2017 Dec; 9(12):1052-1053. PubMed ID: 28792665
[TBL] [Abstract][Full Text] [Related]
8. Improved postprandial glucose control with ultra rapid lispro versus lispro with continuous subcutaneous insulin infusion in type 1 diabetes: PRONTO-Pump-2.
Warren M; Bode B; Cho JI; Liu R; Tobian J; Hardy T; Chigutsa F; Phillip M; Horowitz B; Ignaut D
Diabetes Obes Metab; 2021 Jul; 23(7):1552-1561. PubMed ID: 33687783
[TBL] [Abstract][Full Text] [Related]
9. Continuous Glucose Monitoring in Older Adults With Type 1 and Type 2 Diabetes Using Multiple Daily Injections of Insulin: Results From the DIAMOND Trial.
Ruedy KJ; Parkin CG; Riddlesworth TD; Graham C;
J Diabetes Sci Technol; 2017 Nov; 11(6):1138-1146. PubMed ID: 28449590
[TBL] [Abstract][Full Text] [Related]
10. Influence of Fasting Glucose Levels on Achieving Glycemic Target in Individuals with Type 2 Diabetes: a Post Hoc Analysis.
Ma J; Lei M; Li Y; Zhang X; Cui N; Yang W
Adv Ther; 2020 Sep; 37(9):3816-3826. PubMed ID: 32671687
[TBL] [Abstract][Full Text] [Related]
11. Baseline Glycated Hemoglobin Values Predict the Magnitude of Glycemic Improvement in Patients with Type 1 and Type 2 Diabetes: Subgroup Analyses from the DIAMOND Study Program.
Billings LK; Parkin CG; Price D
Diabetes Technol Ther; 2018 Aug; 20(8):561-565. PubMed ID: 30044123
[TBL] [Abstract][Full Text] [Related]
12. Time spent in target range assessed by self-monitoring blood glucose associates with glycated hemoglobin in insulin treated patients with diabetes.
Cutruzzolà A; Irace C; Parise M; Fiorentino R; Pio Tripodi PF; Ungaro S; Babinsky V; Gnasso A
Nutr Metab Cardiovasc Dis; 2020 Sep; 30(10):1800-1805. PubMed ID: 32669240
[TBL] [Abstract][Full Text] [Related]
13. Improved Postprandial Glucose with Inhaled Technosphere Insulin Compared with Insulin Aspart in Patients with Type 1 Diabetes on Multiple Daily Injections: The STAT Study.
Akturk HK; Snell-Bergeon JK; Rewers A; Klaff LJ; Bode BW; Peters AL; Bailey TS; Garg SK
Diabetes Technol Ther; 2018 Oct; 20(10):639-647. PubMed ID: 30207748
[TBL] [Abstract][Full Text] [Related]
14. Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis.
Yeh HC; Brown TT; Maruthur N; Ranasinghe P; Berger Z; Suh YD; Wilson LM; Haberl EB; Brick J; Bass EB; Golden SH
Ann Intern Med; 2012 Sep; 157(5):336-47. PubMed ID: 22777524
[TBL] [Abstract][Full Text] [Related]
15. Ultra-Rapid Lispro Efficacy and Safety Compared to Humalog® in Japanese Patients With Type 2 Diabetes: PRONTO-T2D Subpopulation Analysis.
Jinnouchi H; Imori M; Nishiyama H; Imaoka T
Diabetes Ther; 2020 Sep; 11(9):2075-2088. PubMed ID: 32728833
[TBL] [Abstract][Full Text] [Related]
16. Glycaemia in low-premixed insulin analogue type 2 diabetes patients in a real-world setting: are the CGM targets met?
Krajnc M; Kravos Tramšek NA
Eur J Med Res; 2023 Mar; 28(1):111. PubMed ID: 36882852
[TBL] [Abstract][Full Text] [Related]
17. Influence of Fasting Plasma Glucose Targets on Glycemic Variability in Chinese Participants With Type 2 Diabetes: A Post Hoc Analysis of the FPG GOAL Trial (BEYOND III).
Li L; Yang T; Xue Y; Ruan P; Du J; Li Y; Zhang X; Cui N; Yang W
Adv Ther; 2022 Jan; 39(1):421-429. PubMed ID: 34757600
[TBL] [Abstract][Full Text] [Related]
18. Ultra-Rapid Lispro Efficacy and Safety Compared to Humalog
Miura J; Imori M; Nishiyama H; Imaoka T
Diabetes Ther; 2020 Sep; 11(9):2089-2104. PubMed ID: 32728832
[TBL] [Abstract][Full Text] [Related]
19. Time in Range Estimation in Patients with Type 2 Diabetes is Improved by Incorporating Fasting and Postprandial Glucose Levels.
Sun R; Duan Y; Zhang Y; Feng L; Ding B; Yan R; Ma J; Su X
Diabetes Ther; 2023 Aug; 14(8):1373-1386. PubMed ID: 37328714
[TBL] [Abstract][Full Text] [Related]
20. Ultra rapid lispro improves postprandial glucose control compared with lispro in patients with type 1 diabetes: Results from the 26-week PRONTO-T1D study.
Klaff L; Cao D; Dellva MA; Tobian J; Miura J; Dahl D; Lucas J; Bue-Valleskey J
Diabetes Obes Metab; 2020 Oct; 22(10):1799-1807. PubMed ID: 32488923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
